4.5 Article

Rare and de novo duplications containing SHOX in clubfoot

Journal

JOURNAL OF MEDICAL GENETICS
Volume 57, Issue 12, Pages 851-857

Publisher

BMJ PUBLISHING GROUP
DOI: 10.1136/jmedgenet-2020-106842

Keywords

aneuploidy; copy-number; complex traits; genetics; molecular genetics

Funding

  1. National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01AR067715]
  2. Eunice Kennedy Shriver National Institutes of Child Health and Human Development of the National Institutes of Health [P01HD084387]
  3. Marfan Foundation Faculty Grant [81831]
  4. Washington University Institute of Clinical and Translational Sciences grant from the National Center for Advancing Translational Sciences of the National Institutes of Health [UL1 TR002345]
  5. Washington University Musculoskeletal Research Center [NIH/NIAMS P30 AR057235]
  6. Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health [U54 HD087011]
  7. NCI Cancer Center Support Grant [P30 CA91842]
  8. ICTS/CTSA from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH) [UL1RR024992]
  9. NIH Roadmap for Medical Research
  10. NIH [1S10RR022984-01A1, 1S10OD018091-01]

Ask authors/readers for more resources

Introduction Congenital clubfoot is a common birth defect that affects at least 0.1% of all births. Nearly 25% cases are familial and the remaining are sporadic in inheritance. Copy number variants (CNVs) involving transcriptional regulators of limb development, including PITX1 and TBX4, have previously been shown to cause familial clubfoot, but much of the heritability remains unexplained. Methods Exome sequence data from 816 unrelated clubfoot cases and 2645 in-house controls were analysed using coverage data to identify rare CNVs. The precise size and location of duplications were then determined using high-density Affymetrix Cytoscan chromosomal microarray (CMA). Segregation in families and de novo status were determined using qantitative PCR. Results Chromosome Xp22.33 duplications involving SHOX were identified in 1.1% of cases (9/816) compared with 0.07% of in-house controls (2/2645) (p=7.98x10(-5), OR=14.57) and 0.27% (38/13592) of Atherosclerosis Risk in Communities/the Wellcome Trust Case Control Consortium 2 controls (p=0.001, OR=3.97). CMA validation confirmed an overlapping 180.28 kb duplicated region that included SHOX exons as well as downstream non-coding regions. In four of six sporadic cases where DNA was available for unaffected parents, the duplication was de novo. The probability of four de novo mutations in SHOX by chance in a cohort of 450 sporadic clubfoot cases is 5.4x10(-10). Conclusions Microduplications of the pseudoautosomal chromosome Xp22.33 region (PAR1) containing SHOX and downstream enhancer elements occur in similar to 1% of patients with clubfoot. SHOX and regulatory regions have previously been implicated in skeletal dysplasia as well as idiopathic short stature, but have not yet been reported in clubfoot. SHOX duplications likely contribute to clubfoot pathogenesis by altering early limb development.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available